IO Biotech, Inc. (IOBTQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.000099 (-99.00%)
At close: Nov 19, 2026
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $72 as of November 19, 2026. It is the 51,994th most valuable company in the world and the 7,906th biggest in the United States. Its market cap has decreased by 100.00% in one year.
Market Cap
72.00
Enterprise Value
-12.54M
Revenue
n/a
Global Rank
Country Rank
#7,906 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 8, 2021, IO Biotech's market cap has decreased from 364.82M to 72.00, a decrease of -100.00%. That is a compound annual growth rate of -95.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 72.00 | -100.00% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -49.45% |
| Nov 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneLink | 10.60K |
| Bioasis Technologies | 7.94K |
| Statera Biopharma | 7.26K |
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.17K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |